Why is Ipca Labs falling/rising?

As of 10-Nov, Ipca Laboratories Ltd is experiencing a price increase, currently at 1,348.20, reflecting a rise of 26.45 or 2.0%. The stock has shown a positive trend, gaining 4.08% over the last three days and outperforming its sector by 0.95% today. Additionally, the stock's performance over the past week has been strong, with a return of +2.92%, while it has underperformed the benchmark Sensex over the past month with a return of +1.05%. The company has demonstrated solid financial health, with positive results for the last five consecutive quarters, including a significant growth in profit after tax and a low debt-to-equity ratio. High institutional holdings at 47.2% suggest confidence from larger investors, which may contribute to the stock's upward movement. In the broader market context, while the Sensex has seen a slight decline of -0.53% over the past week, Ipca Laboratories has managed to rise, indicating a divergence from the overall market trend. The stock's year-to-date performance shows a decline of -20.30%, contrasting with the Sensex's gain of +6.91%, but the recent positive momentum may suggest a potential recovery phase. The stock's liquidity, indicated by a significant increase in delivery volume, further supports the notion of rising investor interest, which could be a factor in its current price increase.